BASTIDE
Public limited company with capital of 3,309,983.55 euros
The head office :
12, avenue de la Dame, Euro zone 2000
30132 Caissargues
305 635 039 RCS NIMES
Description of the share buyback program voted by the shareholders
at the Combined General Meeting of December 14, 2022
In accordance with the provisions of Article 5 of Regulation 596/2014, Article 2 of Delegated Regulation 2016/1052 and Article 241-2 of the AMF General Regulation, the purpose of this description is to describe the purposes and terms of the program to buy back its own shares by the company.
1) Date of the General Meeting authorizing the share buyback program
December 14, 2022
2) Number of securities and share of capital that the issuer holds directly or indirectly:
On December 14, 2022, the company held 52,066 treasury shares, i.e. 0.708% of the capital.
3) Breakdown by objectives of equity securities held by the Company
1,883 shares under the AMAFI liquidity contract
21,849 shares under the repurchase agreement,
28,334 own shares.
4) Objectives of the buyback program
Acquisitions may be made for:
– to ensure the animation of the secondary market or the liquidity of the Bastide le confort medical share through an investment service provider through a liquidity contract in accordance with the code of ethics of the AMAFI admitted by the AMF;
– to keep the shares purchased and return them later for exchange or payment in the context of any external growth operations, it being specified that the shares acquired for this purpose may not exceed 5% of the company’s capital;
– to ensure coverage of stock option plans and other forms of share allocation to employees and/or corporate officers of the group under the conditions and according to the procedures provided for by law, in particular in respect of participation in the results of the company, in respect of a company savings plan or by free allocation of shares within the framework of the provisions of article L.225-197-1 and following of the Trade code ;
– to ensure the cover of transferable securities giving right to the allocation of shares of the company within the framework of the regulations in force;
– proceed with the possible cancellation of the shares acquired
5) Maximum share of capital, maximum number and characteristics of securities that the company proposes to acquire and maximum purchase price
The general meeting of December 14, 2022 authorized the company Bastide to proceed with the purchase of shares of the company within the limit of 10% of the number of shares making up the share capital, i.e. on the basis of the current capital, 7,355. 519 shares. Also, the amount of the program may not be greater than the amount of free reserves determined in the annual financial statements for the current financial year.
Given the number of shares held on December 14, 2022, i.e. 52,066 shares representing 0.708% of the capital, the maximum number of shares that can be purchased under this authorization amounts to 734,000, i.e. a theoretical investment of 51,380. 000 euros on the basis of the maximum purchase price of 70 euros appearing in the seventh resolution of the general meeting of shareholders.
6) Duration of the buyback program
The authorization will expire at the end of the general meeting called to approve the accounts for the financial year ending on June 30, 2023.
This post has the “? Actusnews SECURITY MASTER” service.
– SECURITY MASTER Key:
mHCfk5pvkmidlp9uaJtuZpaXaZqWkmCZZpKcxmlpY5fKb2phmmxkbJuWZnBonG1q
– To check this key:
https://www.security-master-key.com.
Regulated information:
Acquisition or disposal of the issuer’s shares:
– Description of the buyback program
Full and original press release in PDF format:
https://www.actusnews.com/news/77784-2022.12.27-blcm-descriptif-prog-de-rachat-bastide-agm-14.12.2022.pdf
© Copyright Actusnews Wire
Receive the company’s next press releases free of charge by email by subscribing to www.actusnews.com